Cargando…

Antibodies against malondialdehyde among 60-year-olds: prediction of cardiovascular disease

Malondialdehyde (MDA) is generated in oxidized LDL. It forms covalent protein adducts, and is recognized by antibodies (anti-MDA). We previously studied IgM anti-MDA, and here we focus on IgG, IgG1 and IgG2 anti-MDA in predicting cardiovascular disease (CVD). We determined, by ELISA, anti-MDA in a 7...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samal, Shailesh Kumar, Leander, Karin, Vikström, Max, Griesbaum, Lena, de Faire, Ulf, Frostegård, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495339/ https://www.ncbi.nlm.nih.gov/pubmed/37697019 http://dx.doi.org/10.1038/s41598-023-42264-1

Ejemplares similares

Antibodies Against Phosphorylcholine Among 60-Year-Olds: Clinical Role and Simulated Interactions
por: Samal, Shailesh Kumar, et al.
Publicado: (2022)

Human IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60‐Year‐Olds
por: Thiagarajan, Divya, et al.
Publicado: (2016)

IgM antibodies to oxidized phosphatidylserine as protection markers in cardiovascular disease among 60-year olds
por: Frostegård, Johan, et al.
Publicado: (2017)

Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective study
por: Su, Jun, et al.
Publicado: (2013)

Antibodies against Native and Oxidized Cardiolipin and Phosphatidylserine and Phosphorylcholine in Atherosclerosis Development
por: Frostegård, Anna G., et al.
Publicado: (2014)

Antibodies against Malondialdehyde in Haemodialysis Patients and Its Association with Clinical Outcomes: Differences between Subclasses and Isotypes
por: Samal, Shailesh Kumar, et al.
Publicado: (2020)

Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus
por: Anania, Cristina, et al.
Publicado: (2010)

Serum Fatty Acids, Desaturase Activities and Abdominal Obesity – A Population-Based Study of 60-Year Old Men and Women
por: Alsharari, Zayed D., et al.
Publicado: (2017)

IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases
por: Thiagarajan, Divya, et al.
Publicado: (2020)

Chromosome 1p13 genetic variants antagonize the risk of myocardial infarction associated with high ApoB serum levels
por: Gigante, Bruna, et al.
Publicado: (2012)

The Interaction between Coagulation Factor 2 Receptor and Interleukin 6 Haplotypes Increases the Risk of Myocardial Infarction in Men
por: Gigante, Bruna, et al.
Publicado: (2010)

Potential natural immunization against atherosclerosis in hibernating bears
por: Samal, Shailesh Kumar, et al.
Publicado: (2021)

Agreement between Myocardial Infarction Patients and Their Spouses on Reporting of Data on 82 Cardiovascular Risk Exposures
por: Quintana, Hedley Knewjen, et al.
Publicado: (2015)

Immunoglobulin G1 Antibodies Against Phosphorylcholine Are Associated With Protection in Systemic Lupus Erythematosus and Atherosclerosis: Potential Underlying Mechanisms
por: Thiagarajan, D., et al.
Publicado: (2020)

Antibodies against Phosphorylcholine—Implications for Chronic Inflammatory Diseases
por: Frostegård, Johan
Publicado: (2023)

Antibodies against oxidation-specific epitopes and risk of acute myocardial infarction
por: Frostegård, Johan
Publicado: (2023)

Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality
por: Samal, S. K., et al.
Publicado: (2020)

A Swedish primary healthcare prevention programme focusing on promotion of physical activity and a healthy lifestyle reduced cardiovascular events and mortality: 22-year follow-up of 5761 study participants and a reference group
por: Journath, Gunilla, et al.
Publicado: (2020)

Serum IL8 is not associated with cardiovascular events but with all-cause mortality
por: Moreno Velásquez, Ilais, et al.
Publicado: (2019)

Malondialdehyde Conjugated With Albumin Induces Pro-Inflammatory Activation of T Cells Isolated From Human Atherosclerotic Plaques Both Directly and Via Dendritic Cell–Mediated Mechanism
por: Rahman, Mizanur, et al.
Publicado: (2019)

IgM-Antibodies against Phosphorylcholine in Mothers and Normal or Low Birth Weight Term Newborn Infants
por: Frostegård, Anna G., et al.
Publicado: (2014)

The Metabolic Syndrome and ECG Detected Left Ventricular Hypertrophy – Influences from IGF-1 and IGF-Binding Protein-1
por: Halldin, Mats, et al.
Publicado: (2014)

Time Trends in Incidence and Mortality of Acute Myocardial Infarction, and All-Cause Mortality following a Cardiovascular Prevention Program in Sweden
por: Journath, Gunilla, et al.
Publicado: (2015)

Immunity, atherosclerosis and cardiovascular disease
por: Frostegård, Johan
Publicado: (2013)

Financial stress in late adulthood and diverse risks of incident cardiovascular disease and all-cause mortality in women and men
por: Carlsson, Axel C, et al.
Publicado: (2014)

Systemic lupus erythematosus and cardiovascular disease
por: Frostegård, Johan
Publicado: (2022)

Cardiovascular co-morbidity in patients with rheumatic diseases
por: Frostegård, Johan
Publicado: (2011)

Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease
por: Amir, Shahzada, et al.
Publicado: (2012)

Blood Levels of Organochlorine Contaminants Mixtures and Cardiovascular Disease
por: Donat-Vargas, Carolina, et al.
Publicado: (2023)

Effects of Atorvastatin on T‐Cell Activation and Apoptosis in Systemic Lupus Erythematosus and Novel Simulated Interactions With C‐Reactive Protein and Interleukin 6
por: Sun, Jitong, et al.
Publicado: (2021)

Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study
por: Walldius, Göran, et al.
Publicado: (2021)

Humoral immune response to heat shock protein 60 of Aggregatibacter actinomycetemcomitans and cross-reactivity with malondialdehyde acetaldehyde-modified LDL
por: Kyrklund, Mikael, et al.
Publicado: (2020)

Malondialdehyde Level in the Cord Blood
por: Joob, Beuy, et al.
Publicado: (2012)

The Risk of Type 2 Diabetes in Men Is Synergistically Affected by Parental History of Diabetes and Overweight
por: Wikner, Cecilia, et al.
Publicado: (2013)

Depletion of Homeostatic Antibodies against Malondialdehyde-Modified Low-Density Lipoprotein Correlates with Adverse Events in Major Vascular Surgery
por: Hartley, Adam, et al.
Publicado: (2022)

60-year-old Female with Edema
por: Cali, Nikki A., et al.
Publicado: (2022)

Induction of Dendritic Cell–Mediated Activation of T Cells From Atherosclerotic Plaques by Human Heat Shock Protein 60
por: Rahman, Mizanur, et al.
Publicado: (2017)

Cardiovascular program to improve physical fitness in those over 60 years old – pilot study
por: Castillo-Rodríguez, Alfonso, et al.
Publicado: (2014)

Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects
por: Jujić, Amra, et al.
Publicado: (2021)

CYP2D6-inhibiting drugs and risk of fall injuries after newly initiated antidepressant and antipsychotic therapy in a Swedish, register-based case-crossover study
por: Dahl, Marja-Liisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bih85g0tjgtrl2tia82432qqth